Co-administration of ritonavir-boosted protease inhibitors and rate of tenofovir discontinuation in clinical practice.
about
Co-administration of ritonavir-boosted protease inhibitors and rate of tenofovir discontinuation in clinical practice.
description
2014 nî lūn-bûn
@nan
2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
name
Co-administration of ritonavir ...... inuation in clinical practice.
@ast
Co-administration of ritonavir ...... inuation in clinical practice.
@en
Co-administration of ritonavir ...... inuation in clinical practice.
@nl
type
label
Co-administration of ritonavir ...... inuation in clinical practice.
@ast
Co-administration of ritonavir ...... inuation in clinical practice.
@en
Co-administration of ritonavir ...... inuation in clinical practice.
@nl
prefLabel
Co-administration of ritonavir ...... inuation in clinical practice.
@ast
Co-administration of ritonavir ...... inuation in clinical practice.
@en
Co-administration of ritonavir ...... inuation in clinical practice.
@nl
P2093
P2860
P50
P356
P1476
Co-administration of ritonavir ...... inuation in clinical practice.
@en
P2093
Antonella D'Arminio-Monforte
Franco Maggiolo
Giordano Madeddu
Giuseppe Lapadula
Silvia Costarelli
Stefano Bonora
P2860
P356
10.7448/IAS.17.4.19571
P433
P577
2014-11-02T00:00:00Z